Related Experiment Video
Updated: Apr 23, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Novel therapeutic strategies for adult obese asthmatics
Angela L Linderholm1, Jennifer M Bratt1, Gertrud U Schuster2
1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of California, Davis, 4150 V Street, Suite 3100, Davis, CA, USA.
Abstract:
Asthma is a complex syndrome that affects an estimated 26 million people in the United States but gaps exist in the recognition and management of asthmatic subgroups. This article proposes alternative approaches for future treatments of adult obese asthmatics who do not respond to standard controller therapies, drawing parallels between seemingly disparate therapeutics through their common signaling pathways. How metformin and statins can potentially improve airway inflammation is described and supplements are suggested. A move toward more targeted therapies for asthma subgroups is needed. These therapies address asthma and the comorbidities that accompany obesity and metabolic syndrome to provide the greatest therapeutic potential.
Insights
New asthma treatments may help obese adults unresponsive to standard therapies. Metformin and statins show potential for improving airway inflammation and targeting comorbidities like obesity.
Area of Science:
- Pulmonology
- Metabolic Medicine
- Pharmacology
Background:
- Asthma affects 26 million Americans, yet recognition and management of subgroups remain challenging.
- Obese asthmatics often exhibit poor response to standard controller therapies, indicating a need for alternative treatment strategies.
Purpose of the Study:
- To propose novel therapeutic approaches for adult obese asthmatics with refractory symptoms.
- To explore the potential of metformin and statins in managing airway inflammation and associated comorbidities.
Main Methods:
- Literature review and analysis of common signaling pathways.
- Examination of metformin and statin mechanisms relevant to airway inflammation.
- Identification of potential synergistic effects with suggested supplements.
Main Results:
- Metformin and statins present potential mechanisms for improving airway inflammation in obese asthmatics.
- These agents may address comorbidities associated with obesity and metabolic syndrome.
Conclusions:
- Targeted therapies are crucial for specific asthma subgroups, particularly obese individuals.
- Integrating treatments for asthma and its comorbidities offers the greatest therapeutic potential.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Nursing Management
First, in...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:13Asthma III: Clinical Manifestations